Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Classifica tra le azioni #13761
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Prezzo delle azioni
$0.85814713
Ultima sincronizzazione: 2025-05-14
Capitalizzazione di mercato
$463.40M
Variazione (1 giorno)
-2.52%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Alliance Pharma plc (APH)

Categoria

Ricavi di Alliance Pharma plc (APH)
Ricavi nel Dec 2024 TTM: $224.41M
Secondo gli ultimi rapporti finanziari di Alliance Pharma plc, i ricavi attuali dell'azienda (TTM) sono pari a $224.41M. Nel 2023, l'azienda ha registrato ricavi di $230.01M un aumento rispetto a i ricavi dell'anno 2022, che erano pari a $202.54M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Alliance Pharma plc da 2001 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $224.41M 0.00%
2024 $224.41M -2.43%
2023 $230.01M 13.56%
2022 $202.54M -8.21%
2021 $220.65M 24.34%
2020 $177.46M -1.34%
2019 $179.87M 19.46%
2018 $150.56M 7.84%
2017 $139.62M 16.04%
2016 $120.32M 68.90%
2015 $71.24M 5.03%
2014 $67.83M -10.01%
2013 $75.38M 3.50%
2012 $72.83M 2.12%
2011 $71.32M -8.14%
2010 $77.64M 53.57%
2009 $50.56M 59.16%
2008 $31.76M -12.52%
2007 $36.31M 7.34%
2006 $33.83M 60.14%
2005 $21.13M 9.03%
2004 $19.38M 44.44%
2002 $13.42M 51.66%
2001 $8.85M 0.00%
Ricavi di aziende simili o concorrenti